Skip to main content

The Drug Development Paradigm in Oncology Proceedings of a Workshop (2018) / Chapter Skim
Currently Skimming:

Appendix A: Statement of Task
Pages 115-116

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 115...
... • Evidence requirements for cancer therapies before and after regula tory approval, and the mechanisms needed to generate this knowl edge (e.g., clinical trials, "real-world" experiential data, combination approaches)
Read the entire page →

Key Terms

  • recent expedited
  • international regulatory
  • regulatory approaches
  • drug approval
  • approval processes

  • expedited drug
  • cancer therapies
  • tory approval
  • combination approaches
  • clinical trials

  • workshop sessions
  • institutional guidelines
  • experiential data
  • designated rapporteur
  • invite speakers

  • evidence requirements
  • lessons learned


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.